Literature DB >> 9863034

Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery.

D Wang1, D R Robinson, G S Kwon, J Samuel.   

Abstract

A plasmid DNA encoding bacterial beta-galactosidase gene was encapsulated in poly(d,l-lactic-co-glycolic acid) (PLGA) microspheres. Plasmid DNA extracted from PLGA microspheres retained both structural and functional integrity as evidenced by its restriction endonuclease digestion pattern and its ability to transfect COS-1 cells in vitro. PLGA microspheres protected plasmid DNA from digestion by deoxyribonuclease I (DNase I) in vitro. The encapsulation efficiency of plasmid DNA and its release rate depended on the molecular mass of PLGA. Lastly, J-774A macrophages phagocytosed PLGA microspheres loaded with plasmid DNA. Co-encapsulated monophosphoryl lipid A increased the rate of phagocytosis. These results suggest that biodegradable PLGA microspheres can deliver intact and functional plasmid DNA at controlled rates. Thus, PLGA microspheres may be used to jointly deliver genes and other biologically active molecules, e.g., immunomodulators, to antigen presenting cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9863034     DOI: 10.1016/s0168-3659(98)00099-6

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  39 in total

1.  Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro.

Authors:  M E Christine Lutsiak; Deborah R Robinson; Conrad Coester; Glen S Kwon; John Samuel
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Online monitoring of PLGA microparticles formation using Lasentec focused beam reflectance (FBRM) and particle video microscope (PVM).

Authors:  Ahmed S Zidan; Ziyaur Rahman; Mansoor A Khan
Journal:  AAPS J       Date:  2010-03-30       Impact factor: 4.009

3.  Formulation of anastrozole microparticles as biodegradable anticancer drug carriers.

Authors:  Ahmed S Zidan; Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab; Muhammad D Hussain; Mansoor A Khan; Muhammad J Habib
Journal:  AAPS PharmSciTech       Date:  2006-07-21       Impact factor: 3.246

Review 4.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

5.  A comparison between polymeric microsphere and bacterial vectors for macrophage P388D1 gene delivery.

Authors:  Saba Parsa; Yong Wang; Jason Fuller; Robert Langer; Blaine A Pfeifer
Journal:  Pharm Res       Date:  2008-03-15       Impact factor: 4.200

6.  Dynamics of controlled release of heparin from swellable crosslinked starch microspheres.

Authors:  A K Bajpai; Smitha Bhanu
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 3.896

Review 7.  Polymeric growth factor delivery strategies for tissue engineering.

Authors:  Ruth R Chen; David J Mooney
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine.

Authors:  Jeremy S Blum; W Mark Saltzman
Journal:  J Control Release       Date:  2008-04-16       Impact factor: 9.776

9.  Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres.

Authors:  Neelesh K Varde; Daniel W Pack
Journal:  J Control Release       Date:  2007-09-21       Impact factor: 9.776

Review 10.  Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.

Authors:  Ryan G Soderquist; Melissa J Mahoney
Journal:  Expert Opin Drug Deliv       Date:  2010-03       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.